Combined immunohistochemistry for the differential diagnosis of cystic jaw lesions: Its practical use in surgical pathology

Histopathology

Volumn 57, Issue 6, 2010, Pages 806-813

  Tsuneki, Masayuki ^a   Yamazaki, Manabu ^a   Cheng, Jun ^a   Maruyama, Satoshi ^b   Kobayashi, Takanori ^b   Saku, Takashi ^a,b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Differential diagnosis; Immunohistochemistry; Jaw cysts; Lining epithelium; Odontogenic tumours

Indexed keywords

CYCLINE; CYTOKERATIN 10; PERLECAN; TUMOR MARKER;

AMELOBLASTOMA; ARTICLE; DIFFERENTIAL DIAGNOSIS; EPITHELIUM; IMMUNOHISTOCHEMISTRY; JAW CYST; LECTIN BINDING; ODONTOGENIC TUMOR; PATHOLOGY; PERIODONTAL DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TERATOMA;

ADULT; AMELOBLASTOMA; DIAGNOSIS, DIFFERENTIAL; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; JAW DISEASES; ODONTOGENIC TUMORS; PERIODONTAL CYST; RADICULAR CYST; TUMOR MARKERS, BIOLOGICAL;

EID: 78650228956     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03712.x     Document Type: Article

References (24)

1. Ackermann GL, Altini M, Shear M. The unicystic ameloblastoma: a clinicopathological study of 57 cases. J. Oral Pathol. 1988; 17; 541-546.
2. Philipsen HP, Reichart PA. Unicystic ameloblastoma. A review of 193 cases from the literature. Oral Oncol. 1998; 34; 317-325.
3. Robinson L, Martinez MG. Unicystic ameloblastoma: a prognostically distinct entity. Cancer 1977; 40; 2278-2285.
4. Saku T, Shibata Y, Koyama Z, Cheng J, Okabe H, Yeh Y. Lectin histochemistry of cystic jaw lesions: an aid for differential diagnosis between cystic ameloblastoma and odontogenic cysts. J. Oral Pathol. Med. 1991; 20; 108-113.
5. Philipsen HP. Keratocystic odontogenic tumour. In Barnes L, Eveson JW, Reichart P, Sidransky D eds. World Health Organization classification of tumor. Pathology and genetics of head and neck tumours. Lyon: IARC Press, 2005; 306-307.
6. Saku T, Furthmayr H. Characterization of the major heparan sulfate proteoglycan secreted by bovine aortic endothelial cells in culture. Homology to the large molecular weight molecule of basement membranes. J. Biol. Chem. 1989; 264; 3514-3523.
7. Ida-Yonemochi H, Ikarashi T, Nagata M, Hoshina H, Takagi R, Saku T. The basement membrane-type heparan sulfate proteoglycan (perlecan) in ameloblastomas: its intercellular localization in stellate reticulum-like foci and biosynthesis by tumor cells in culture. Virchows Arch. 2002; 441; 165-173.
8. Ikarashi T, Ida-Yonemochi H, Ohshiro K, Cheng J, Saku T. Intraepithelial expression of perlecan, a basement membrane-type heparan sulfate proteoglycan reflects dysplastic changes of the oral mucosal epithelium. J. Oral Pathol. Med. 2004; 33; 87-95.
9. Tsuneki M, Cheng J, Maruyama S, Ida-Yonemochi H, Nakajima M, Saku T. Perlecan-rich epithelial linings as a background of proliferative potentials of keratocystic odontogenic tumor. J. Oral Pathol. Med. 2008; 37; 287-293.
10. Yamazaki M, Cheng J, Hao N et al. Basement membrane-type heparan sulfate proteoglycan (perlecan) and low-density lipoprotein (LDL) are co-localized in granulation tissues: a possible pathogenesis of cholesterol granulomas in jaw cysts. J. Oral Pathol. Med. 2004; 33; 177-184.
11. Ida-Yonemochi H, Ohshiro K, Swelam W, Metwaly H, Saku T. Perlecan, a basement membrane-type heparan sulfate proteoglycan, in the enamel organ: its intraepithelial localization in the stellate reticulum. J. Histochem. Cytochem. 2005; 53; 763-772.
12. Tsuneki M, Cheng J, Yamazaki M et al. Lateral periodontal cyst: a clinicopathological study of 23 cases and an immunohistochemical analysis of its characteristic epithelial plaques in the lining. Oral Med. Pathol. 2008; 12; 89-96.
13. Gardner DG, O'Neill PA. Inability to distinguish ameloblastomas from odontogenic cysts based on expression of blood cell carbohydrates. Oral Surg. Oral Med. Oral Pathol. 1988; 66; 480-482.
14. Vedtofte P, Dabelsteen E. Blood group antigens A and B in ameloblastomas, odontogenic keratocysts and non-keratinizing cysts. Scand. J. Dent. Res. 1975; 83; 96-102.
15. Coleman H, Altini M, Ali H, Doglioni C, Favia G, Maiorano E. Use of calretinin in the differential diagnosis of unicystic ameloblastomas. Histopathology 2001; 38; 312-317.
16. DeVilliers P, Liu H, Suggs C et al. Calretinin expression in the differential diagnosis of human ameloblastoma and keratocystic odontogenic tumor. Am. J. Surg. Pathol. 2008; 32; 256-260.
17. Coleman HG, Altini M, Groeneveld HT. Nucleolar organizer regions (AgNORs) in odontogenic cysts and ameloblastomas. J. Oral Pathol. Med. 1996; 25; 436-440.
18. Yamada K, Tatemoto Y, Okada Y, Mori M. Immunostaining of involucrin in odontogenic epithelial tumors and cysts. Oral Surg. Oral Med. Oral Pathol. 1989; 67; 564-568.
19. Piattelli A, Fioroni M, Santinelli A, Rubini C. Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. Oral Oncol. 1998; 34; 408-412.
20. Stoll C, Stollenwerk C, Riediger D, Mittermayer C, Alfer J. Cytokeratin expression patterns for distinction of odontogenic keratocysts from dentigerous and radicular cysts. J. Oral Pathol. Med. 2005; 34; 558-564.
21. Meara JG, Pilch BZ, Shah SS, Cunningham MJ. Cytokeratin expression in the odontogenic keratocyst. J. Oral Maxillofac. Surg. 2000; 58; 862-865.
22. Hormia M, Ylipaavalniemi P, Nagle RB, Virtanen I. Expression of cytokeratins in odontogenic jaw cysts: monoclonal antibodies reveal distinct variation between different cyst types. J. Oral Pathol. 1987; 16; 338-346.
23. Cheng J, Saku T, Okabe H, Furthmayr H. Basement membranes in adenoid cystic carcinoma. An immunohistochemical study. Cancer 1992; 69; 2631-2640.
24. Li TJ, Browne RM, Matthews JB. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma. Histopathology 1995; 26; 219-228.